Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.54 |
| ▸ | MEN1 | O00255 | 4/20 | 0.54 |
| ▸ | POLB | P06746 | 3/20 | 0.54 |
| ▸ | USP2 | O75604 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.48 |
| ▸ | NCF1 | P14598 | 1/20 | 0.45 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.39 |
| ▸ | TDP2 | O95551 | 2/20 | 0.38 |
| ▸ | APAF1 | O14727 | 1/20 | 0.38 |
| ▸ | CASP3 | P42574 | 1/20 | 0.38 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.38 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.38 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.38 |
| ▸ | HSP90AB1 | P08238 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL544243 | 0.84 | NCF1 (0.54) | MAPTALDH1A1KMT2AKDM4EMEN1 | |
| Hydrochloric Acid SCHEMBL26697692 | 0.82 | NCF1 (0.52) | MAPTALDH1A1KMT2AKDM4EMEN1 | |
| 8-Aminoquinoline SCHEMBL860459 | 0.81 | LMNA (0.53) | MAPTALDH1A1KMT2AKDM4EMEN1 | |
| Quinoxaline SCHEMBL11559513 | 0.77 | NCF1 (0.56) | MAPTALDH1A1KMT2AKDM4EMEN1 | |
| 8-Aminoquinoline SCHEMBL28078884 | 0.76 | ALDH1A1 (0.63) | MAPTALDH1A1KMT2AKDM4EMEN1 | |
| SCHEMBL3069598 | 0.75 | KDM4E (0.58) | MAPTALDH1A1KMT2AKDM4EMEN1 | |
| SCHEMBL17690782 | 0.73 | MEN1 (0.46) | MAPTALDH1A1KMT2AKDM4EMEN1 | |
| SCHEMBL12747772 | 0.71 | KDM4E (0.54) | MAPTALDH1A1KMT2AKDM4EMEN1 | |
| 8-Aminoquinoline SCHEMBL159694 | 0.71 | LMNA (0.61) | MAPTALDH1A1KMT2AKDM4EMEN1 | |
| SCHEMBL3253606 | 0.71 | KDM4E (0.54) | MAPTALDH1A1KMT2AKDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 246 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110867603-B | Polypyrrole-quinoxaline-negative-electrode-based all-water-system mixed flow battery and preparation method thereof | 常州大学 | 2022-03-22 | — | — | CN | claimed |
| CN-110867603-A | Polypyrrole-quinoxaline-negative-electrode-based all-water-system mixed flow battery and preparation method thereof | 常州大学 | 2020-03-06 | — | — | CN | claimed |
| CN-110669058-A | Tricyclic quinolone carboxylic acid and preparation method thereof | 江西农业大学 | 2020-01-10 | — | — | CN | claimed |
| CN-107805223-A | A kind of synthetic method of the sulfonic acid chloride of quinoxaline 5 | 广东莱佛士制药技术有限公司 | 2018-03-16 | — | — | CN | claimed |
| CN-103619846-A | 1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivatives | JANSSEN PHARMACEUTICA NV | 2014-03-05 | — | — | CN | claimed |
| EP-2588144-A2 | DETECTING TARGETS USING MASS TAGS AND MASS SPECTROMETRY | Ventana Medical Systems, Inc. (US) | 2013-05-08 | — | — | EP | claimed |
| WO-2012003478-A2 | DETECTING TARGETS USING MASS TAGS AND MASS SPECTROMETRY | VENTANA MEDICAL SYSTEMS, INC. (US) | 2012-01-05 | — | — | WO | claimed |
| CN-100503581-C | Poly (5-aminoquinoxaline) and its use | NISSAN CHEMICAL IND LTD (JP) | 2009-06-24 | — | — | CN | claimed |
| EP-1361244-B1 | Poly(5-aminoquinoxalines); preparation and use thereof | NISSAN CHEMICAL IND LTD (JP) | 2006-10-18 | — | — | EP | claimed |
| US-6822069-B2 | CAN BE APPLIED AS AN ACTIVE SUBSTANCE OR AN ELECTRODE MATERIAL FOR A BATTERY, AN ORGANIC ELECTROLUMINESCENCE DEVICE MATERIAL, A SEMICONDUCTOR, AND A NONLINEAR-TYPE OPTICAL MATERIAL | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2004-11-23 | — | — | US | claimed |
| US-20030215701-A1 | Poly (5-aminoquinoxalines) and use thereof | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2003-11-20 | — | — | US | claimed |
| CN-1456554-A | Poly (5-aminoquinoxaline) and its use | NISSAN CHEMICAL IND LTD (JP) | 2003-11-19 | — | — | CN | claimed |
| EP-1361244-A1 | Poly(5-aminoquinoxalines); preparation and use thereof | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 2003-11-12 | — | — | EP | claimed |
| EP-0341476-A2 | 4-Aza-1,10-phenanthroline derivates | BAYER AG (DE) | 1989-11-15 | — | — | EP | claimed |
| JP-1319483-A | — | — | None | — | — | JP | disclosed |
| US-12606533-B2 | 3-phenylpropylamine derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2026-04-21 | — | — | US | disclosed |
| US-20250353824-A1 | 3-PHENYLPROPYLAMINE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2025-11-20 | — | — | US | disclosed |
| JP-H01319483-A | 4-AZA-1,10-PHENANTHROLINE DERIVATIVE | BAYER AG | 1989-12-25 | — | — | JP | disclosed |
| EP-0341476-A2 | 4-Aza-1,10-phenanthroline derivates | BAYER AG (DE) | 1989-11-15 | — | — | EP | disclosed |
| EP-0341476-A2 | 4-Aza-1,10-phenanthroline derivates | BAYER AG (DE) | 1989-11-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250353824-A1 | 3-PHENYLPROPYLAMINE DERIVATIVE | SF1, SF3A1, SFXN1 | MAPT 2719/4885ALDH1A1 358/4885KMT2A 1381/4885 |
| US-12606533-B2 | 3-phenylpropylamine derivative | SF3A1, SF1, HTR1D | MAPT 4210/4885ALDH1A1 357/4885KMT2A 1072/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.